(Q33348393)

English

A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

David Shaffer

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Anthony Langone

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

William A Nylander

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Simin Goral

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A Tarik Kizilisik

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

J Harold Helderman

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

17 Suppl 9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

31-34

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.17.S9.5.X

21 January 2018

A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.17.S9.5.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.17.S9.5.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.17.S9.5.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.17.S9.5.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Short course induction immunosuppression with thymoglobulin for renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.17.S9.5.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-0012.17.S9.5.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33348393&oldid=1536720436"